GL1X · GenesisL1 explorer

MolNFT v1 · #137823 · protein

Crebbp bromodomain in complex with CPD8 (1-(3-(7-(difluoromethyl)-6- (1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-1- (tetrahydrofuran-3-yl)-1,4,6,7-tetrahydro-5H-PYRAZOLO[4,3-C]PYRIDIN- 5-YL)ETHAN-1-one)

5W0I · Creb-binding protein: “Crebbp bromodomain in complex with CPD8 (1-(3-(7-(difluoromethyl)-6…”. X-ray diffraction, 1 ligand (9UA), 1 pocket (best druggability 0.46). MolNFT v1 #137823 on GenesisL1: 3D structure, binding sites and…

PDB
5W0I
Type
protein
Length
114 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Creb-binding protein
EC
2.3.1.48
UniProt
P45481
Ligands
9UA
Pockets
1 · best druggability 0.46

Structure

x-ray diffraction · 1 distinct chain · 68% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACreb-binding protein (EC 2.3.1.48)protein11468% helix, 0% strandP45481

Ligands and binding sites

  • 9UA · 1-{3-[7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl]-1-[(3S)-oxolan-3-yl]-1, 4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}ethan-1-one · ligand · chains A
  • DMS · Dimethyl sulfoxide · additive · 2 copies · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1810.460.81189UA

Compared structures

  • 5W0I · CREBBP Bromodomain in complex with Cpd8 (1-(3-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4… · the same entry in another collection · chain A against A, TM-score 1.00
  • P45481 · AlphaFold monomer V2.0 prediction for histone lysine acetyltransferase crebbp (P45481) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.